← Back to Search

Opioid System's Role in Placebo Effects for Pain

Phase < 1
Waitlist Available
Led By Tor D Wager, PhD
Research Sponsored by Trustees of Dartmouth College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No current or recent history of pathological pain or reported neurological disorders
No current psychiatric or major neurological diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after pain/rejection stimuli
Awards & highlights

Study Summary

This trial is investigating whether the opioid system is involved in the placebo effect of social pain relief. 60 participants who have recently experienced an unwanted breakup will be exposed to rejection-related stimuli and given painful heat and pressure stimuli during fMRI scanning. They will be randomized to receive either a naloxone or saline nasal spray, and be told that the spray is either saline or an effective pain and negative emotion reducing agent.

Who is the study for?
This trial is for adults aged 18-55 who speak English and have recently gone through an unwanted breakup. They must not have psychiatric/neurological disorders, substance abuse history in the last six months, or any conditions that would interfere with MRI scanning. Participants should not be on certain medications or have metal implants due to MRI requirements.Check my eligibility
What is being tested?
The study tests how a placebo cream combined with either naloxone (blocks opioid effects) or saline affects pain and feelings of social rejection after a breakup. During fMRI scans, participants will face rejection stimuli and painful sensations while being told they're receiving a treatment that could reduce pain and negative emotions.See study design
What are the potential side effects?
Since this trial involves placebos and naloxone which may temporarily block natural pain-relief mechanisms, possible side effects include increased sensitivity to pain or discomfort during the testing period.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have ongoing or recent severe pain or neurological disorders.
Select...
I do not have a psychiatric or major neurological condition.
Select...
I am between 18 and 55 years old.
Select...
I am fluent in English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after rejection stimuli
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after rejection stimuli for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brain: Pain signature response
Brain: Rejection signature response
Heart rate
+3 more
Secondary outcome measures
Rejection Sensitivity Questionnaire
Whole-brain maps of intervention effects

Trial Design

2Treatment groups
Experimental Treatment
Group I: Saline GroupExperimental Treatment2 Interventions
Participants will receive saline in the nasal spray.
Group II: Naloxone GroupExperimental Treatment2 Interventions
Participants will receive 4mg naloxone nasal spray.

Find a Location

Who is running the clinical trial?

Trustees of Dartmouth CollegeLead Sponsor
23 Previous Clinical Trials
10,625 Total Patients Enrolled
2 Trials studying Pain
270 Patients Enrolled for Pain
Tor D Wager, PhDPrincipal InvestigatorDartmouth College
5 Previous Clinical Trials
473 Total Patients Enrolled
2 Trials studying Pain
270 Patients Enrolled for Pain

Media Library

Control Cream with Naloxone Clinical Trial Eligibility Overview. Trial Name: NCT04650841 — Phase < 1
Pain Research Study Groups: Saline Group, Naloxone Group
Pain Clinical Trial 2023: Control Cream with Naloxone Highlights & Side Effects. Trial Name: NCT04650841 — Phase < 1
Control Cream with Naloxone 2023 Treatment Timeline for Medical Study. Trial Name: NCT04650841 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial recruiting participants currently?

"According to the clinicaltrials.gov site, this investigation is not presently recruiting participants, though it was initially listed on September 1st 2023 and most recently edited on October 25th 2022. However, there are 382 other trials across multiple sites that are currently seeking patients."

Answered by AI

Is eligibility for participation in the trial limited to individuals over 25 years old?

"Those that wish to take part in this clinical trial must have reached the age of majority and not yet exceeded 55 years."

Answered by AI

Could you provide a synopsis of prior experiments involving Control Cream with Naloxone?

"Presently, the Control Cream with Naloxone has achieved Phase 3 in 9 distinct clinical trials. The majority of these are being conducted at Durham, North carolina; however, 119 other medical sites around USA are also participating in research for this medication."

Answered by AI

What is the population size of participants involved in this experiment?

"As of the last update on October 25th 2022, this research trial is not actively recruiting subjects. If you are still in search of a medical study to participate in, there are presently 344 clinical trials seeking patients related to placebo effect and 38 studies requiring volunteers for Control Cream with Naloxone."

Answered by AI

Who qualifies to enroll in this clinical research?

"Patients between the ages of eighteen and fifty-five who have a placebo effect are eligible to take part in this clinical trial. Around sixty participants will be selected."

Answered by AI

In what clinical applications is Control Cream with Naloxone predominantly utilized?

"Control Cream with Naloxone is a versatile medication that can be used for the treatment of opioid addiction and other conditions such as pain, pruritus, and septic shock."

Answered by AI
~40 spots leftby Mar 2025